ADVFN Logo

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

IDEA Ideagen Plc

349.00
0.00 (0.00%)
Last Updated: 00:00:00
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Ideagen Plc LSE:IDEA London Ordinary Share GB00B0CM0C50 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 349.00 0.00 00:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
0 0 N/A 0

Ideagen PLC Issue of Shares, PDMR Dealing & TVR (4797V)

14/04/2021 12:40pm

UK Regulatory


Ideagen (LSE:IDEA)
Historical Stock Chart


From Mar 2021 to Mar 2024

Click Here for more Ideagen Charts.

TIDMIDEA

RNS Number : 4797V

Ideagen PLC

14 April 2021

14 April 2021

Ideagen PLC

("Ideagen," the "Company" or the "Group")

Issue of new Shares under the Share Incentive Plan, PDMR Dealing & Total Voting Rights

Ideagen PLC (AIM: IDEA), a leading supplier of Information Management Software to highly regulated industries, announces that it has allotted a total of 3,386 new ordinary shares of 1 penny each in the capital of the Company ("Ordinary Shares") following the purchase of 3,386 Ordinary Shares by a number of employees in aggregate under the Company's Share Incentive Plan ("SIP"). In addition, the Company has also applied for 2,213,333 Ordinary Shares to be admitted to trading on AIM. These shares were issued and allotted on 17 October 2019, and announced as such on that date, but the clerical procedures for ensuring admission to trading on AIM were not fully completed.

Application has been made to the London Stock Exchange for 3,386 new Ordinary Shares and 2,213,333 Ordinary Shares to be admitted to trading on AIM ("Admission") and it is expected that Admission will become effective and trading will commence at 8.00 a.m. on 20 April 2021.

After Admission, the total number of Ordinary Shares in issue will be 252,298,765 and the total number of voting rights will therefore be 252,298,765. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the FCA's Disclosure and Transparency Rules.

In addition to the above, Elizabeth Hewitt, the wife of Alex Hewitt, Chief Legal Officer, has sold 8,000 ordinary shares of 1 penny each in the capital of the Company ("Ordinary Shares") at a price of 291 pence on 9 April 2021. Following the sale of shares, Mr Hewitt has a beneficiary interest in 108,095 shares, representing 0.05% of the issued share capital of the Company.

This announcement contains inside information for the purposes of Article 7 of Regulation (EU) No 596/2014.

Enquiries:

 
Ideagen plc                           01629 699 100 
David Hornsby, Executive Chairman 
 
Ben Dorks, Chief Executive Officer 
Emma Hayes, Chief Financial Officer 
 
finnCap Limited                       020 7220 0500 
Henrik Persson/James Thompson 
 (Nomad) 
Alice Lane (ECM) 
Canaccord Genuity                     020 7523 8000 
Simon Bridges 
Richard Andrews 
 

About Ideagen plc

Ideagen is a UK-headquartered, global technology company quoted on the London Stock Exchange AIM market (Ticker: IDEA.L).

A global supplier of regulatory and compliance solutions, Ideagen provides a common software platform and an integrated risk-based approach to meet multi-industry standards, enabling compliance with relevant laws, policies, and regulations.

The Group provides software and services to organisations operating within highly regulated industries such as life sciences, healthcare, banking and finance, insurance, aviation, and aerospace and defence, with its main operational premises spread throughout the UK, EU, US, Middle East and SE Asia.

Currently, more than 5,700 organisations use Ideagen's products including nine of the top 10 UK accounting firms, all of the top aerospace and defence companies and 75% of the world's leading pharmaceutical firms.

Ideagen's diverse and varied customer base includes many well-known, global brands such as British Airways, Aggreko, BAE, Ryanair, US Navy, KLM, BBVA, Bank of New York, Commerzbank, Meggitt, Heineken, Johnson Matthey, Haeco Group and European Central Bank. As well as this, Ideagen counts 250 hospitals across the UK and US amongst its client base. For further information please visit www.ideagen.com .

 
 1.   Details of the person discharging managerial responsibilities / person closely associated 
 a)   Name                                              Elizabeth Hewitt 
     ------------------------------------------------  --------------------------------------------- 
 2.   Reason for the Notification 
     ----------------------------------------------------------------------------------------------- 
 a)   Position/status                                   PCA to Alex Hewitt Chief Legal 
                                                         Officer 
     ------------------------------------------------  --------------------------------------------- 
 b)   Initial notification/Amendment                    Initial notification 
     ------------------------------------------------  --------------------------------------------- 
 3.   Details of the issuer, emission allowance market participant, auction platform, auctioneer 
       or auction monitor 
     ----------------------------------------------------------------------------------------------- 
 a)   Name                                              Ideagen plc 
     ------------------------------------------------  --------------------------------------------- 
 b)   LEI                                               213800KS1MLITOVNYC85 
     ------------------------------------------------  --------------------------------------------- 
 4.   Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) 
       each type of transaction; (iii) each date; and (iv) each place where transactions have been 
       conducted 
     ----------------------------------------------------------------------------------------------- 
 a)   Description of the Financial                      Ordinary Shares of 1p each 
       instrument, type of instrument 
     ------------------------------------------------  --------------------------------------------- 
      Identification code                               GB00B0CM0C50 
     ------------------------------------------------  --------------------------------------------- 
 b)   Nature of the transaction                         Sale of shares 
     ------------------------------------------------  --------------------------------------------- 
 c)   Price(s) and volume(s)                             Price(s)     Volume(s) 
                                                          291 pence    8,000 
                                                                      ---------- 
     ------------------------------------------------  --------------------------------------------- 
 d)   Aggregated information:                           Sale of 8,000 ordinary shares 
       -- Aggregated volume                              at 291 pence per share 
       -- Price 
     ------------------------------------------------  --------------------------------------------- 
 e)   Date of the transaction                           9 April 2021 
     ------------------------------------------------  --------------------------------------------- 
 f)   Place of the transaction                          AIM 
     ------------------------------------------------  --------------------------------------------- 
 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

DSHBBGDSIXBDGBS

(END) Dow Jones Newswires

April 14, 2021 07:40 ET (11:40 GMT)

1 Year Ideagen Chart

1 Year Ideagen Chart

1 Month Ideagen Chart

1 Month Ideagen Chart

Your Recent History

Delayed Upgrade Clock